As oncology drug developers, you likely know that selecting the proper Contract Research Organization (CRO) for your Phase 1 clinical trial is a crucial step in bringing your treatment to the market. This article provides insights for oncology drug developers when selecting a CRO for an Early Phase Oncology Trial.
What is a CRO?
A CRO is a company that specializes in contract research and development. They help companies by providing the services they need to conduct their research – from designing and carrying out tests to procuring and shipping samples to researchers. CROs typically have a wide range of experience, from conducting fundamental research to more complex projects. In addition, most CROs offer their clients access to a large pool of talented researchers.
Benefits of working with a CRO for your Early Phase Oncology Trials
A contract research organization (CRO) can be a valuable asset for oncology drug developers. Benefits of using a CRO include:
- Reduced cycle time. A CRO can help speed development by providing resources and expertise in data management, clinical trial design, and study monitoring.
- Increased efficiency. A CRO can help reduce the number of interactions required with various stakeholders, allowing more time to focus on the actual development of the drug.
- Reduced risk. A CRO is typically more experienced and knowledgeable than individual researchers regarding complex clinical trial protocols and study designs. This means there is less risk of errors or missteps during development.
- Improved communication and collaboration. A CRO can help ensure that all stakeholders are up-to-date on project milestones and developments, leading to improved collaboration and communication between team members.
One of the challenges for oncology drug developers is finding a CRO specializing in Early Phase clinical trials. Adding oncology to the mix makes that challenge even more significant.
A CRO with Early Phase Oncology Expertise
So, a CRO’s focus is essential. Be sure to enquire about their organization’s expertise in early phase clinical trials. Some CROs may focus more on this type of trial, while others may be more generalists. Suppose a CRO only has experience conducting later-phase clinical trials. In that case, it may not be able to adequately guide your project through all of the unique challenges and pitfalls that can occur during early phase clinical trials.
And find out whether the CRO has any experience working with your target cancer type or drugs. For example, if your target cancer is rare or your drug is not yet available on the market, a CRO that is inexperienced with this type of project may not be able to provide adequate support.
Things to keep in mind when choosing a CRO for your Phase 1 Oncology Trial:
- Make sure the CRO has the experience you need. They should be able to provide you with information on specific projects and research areas and help you find researchers who can meet your needs.
- Make sure the CRO is reputable. Look for organizations that have been in business for many years and have a good reputation among scientists.
- Be sure to discuss your project with the CRO before starting it. They can advise on how best to carry out your research and help you find the resources necessary for your project. When hiring a CRO, it is essential to ask these questions: – What kind of projects does this company do? Do they have a variety of research areas?- What kinds of services will the CRO provide? Will they assist in finding suitable researchers or other individuals to work on your project?- How long has the organization been around, and what are its credentials?
- Ask whether the CRO is affiliated with a university or medical institution. Some CROs are affiliated with academic institutions, which can provide additional resources and support.
- Determine whether the CRO has national accreditation and, if so, what type of accreditation it holds. Accreditation indicates that a CRO has demonstrated professionalism and experience conducting clinical trials.
- Check the CRO’s website to learn more about its history and areas of expertise. For example, a well-established company will have many years of experience in the field. In contrast, a new company may be focused on particular types of clinical trials and research endeavours.
- Contact references from previous clients to find out what kind of support they received from the company or service. A good service provider will have several satisfied clients who can attest to the quality of its services and its responsiveness to the needs of its customers and patients.
Like anything else you purchase, or consider purchasing, make sure you’re getting value for your money.
How CROs are Used in Early Phase Oncology
Contract research organizations (CROs) have become an integral part of the drug development process for oncology drugs. They play a vital role by providing a cost-effective means to test new cancer therapies in humans. Additionally, CROs can help speed up drug development by performing preclinical and clinical trials more efficiently. However, choosing the right CRO is crucial for success in oncology drug development.
Below are five tips for selecting the best CRO for your oncology drug project:
1. Evaluate your project’s needs. Before hiring a CRO, it’s vital to assess what services they offer and whether those services are necessary for your project. For example, some CROs specialize in certain areas of drug development, such as clinical trials or preclinical testing. Make sure to ask which areas of drug development they are experienced in and whether they have the necessary resources to complete your project successfully.
2. Consider budget constraints. Although not all CROs charge equal rates, budget is always a factor when choosing a CRO. It’s crucial to find a CRO that charges a reasonable rate that reflects the quality of its services. Some good quality indicators include experience, track record, the number of clients the CRO works with, and professional accreditation.
3. Ask about time constraints. When considering a potential CRO, ask if they have time constraints when it comes to completing your project successfully. For example, for some projects, you need to work quickly and expect that the CRO will be able to complete the project within a specific time. If this is the case, ask when that period is and how long it usually takes them to complete such projects.
4. Consider how many people will be working on your project at a given time. Certain CROs may not have enough people available to work on your project at all times, but others do have the staff resources you need when needed most. To find out which kind of CRO will be able to deliver the best results, you need to ask the right questions. For example, ask how many employees work there, their experience level and what type of projects they can complete most successfully.
5. Consider where your project is being done. You likely want a CRO that can do what it takes to deliver on time and with the quality, you’re looking for – especially if you’ll be paying them for the project. Consider whether or not this company offers finished products in your country and if they have previously completed other projects in your area of expertise.
As a drug developer, you have many responsibilities and tasks that need to be completed to bring your product to market. One of the most important decisions you will make is who will do the contracted research on your behalf—choosing the proper contract research organization for your project and some key considerations to keep in mind. By following these tips, you can ensure that your contracted research is executed successfully and meets all of your expectations.
Running A Clinical Trial In Kazakstan
Moving Clinical Trials away from Ukraine and Russia For a long time, Russia, Ukraine and other countries in the Commonwealth of Independent States (CIS) have been the host of ample clinical trials in various therapeutic areas. And for a good reason: countries in the...
How to Avoid Delays in Your Early Phase Oncology Trial?
Webinar: How to Avoid Delays in Your Early Phase Oncology Trial? Many things can go array in your early phase oncology trials, from protocol development, taking care of a safety profile, getting the ethics committee / regulatory authority’s approval, managing vendors,...
Q&A. How does the conflict between UA & RU impact the pharma industry?
Webinar: How does the conflict between UA & RU impact the pharma industry? Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And with good reason. Russia's invasion of Ukraine...
How does the Russian invasion impact the pharmaceutical industry?
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And, with good reason. Russia's invasion of Ukraine affects millions of people, not just in this Eastern European nation but...
How To Manage An Early Phase Oncology Study: Project Manager Insights
Clinical development of oncology drugs has one of the lowest success rates of the development of Investigational New Drugs (INDs) for all disease categories, with less than 7% of phase I-tested oncology drugs achieving market approval. Moreover, the clinical...
How To Improve Patient Recruitment In Early Phase Oncology Trials
The difficulties of recruiting in clinical trials, and particularly cancer patients in their early stages, can significantly obstruct the development of innovative treatments. There is an undeniable increase in demand for Early Phase Clinical studies in patients to...
What are the advantages of a hospital-based Early Phase Unit?
Choosing the right setting for your early phase trial can be challenging. As a sponsor, it's natural to remain cautious about running more extensive early-phase patient trials in a single Phase I unit due predominantly to the doubt over actually being able to recruit...
Biomapas joins SwedenBIO organization
December 2021 Biomapas has joined the SwedenBIO organization starting November 2021. Joining SwedenBIO's mission to promote an environment bringing success and growth to the entire Swedish life science industry, we seek to walk the path in developing the life sciences...
What are the Challenges of Decentralized Clinical Trials?
The COVID-19 pandemic has accelerated the adoption of decentralized clinical trials by emphasizing the tangible advantages of virtual trials and their ability to improve the patient and physician experience. Moreover, it requires stakeholders to devote time and...
Challenges In Early Phase Oncology Trials
Cancer is the biggest cause of mortality globally, with 19.3 million new cases and over 10 million deaths expected in 2020. By 2040, the worldwide cancer burden is predicted to reach 28.4 million cases. Female breast cancer is the most often diagnosed type of cancer,...